Modular Medical Finalizes $12M Public Offering at Premium, Securing Critical Funding Amid Liquidity Crisis

summarizeSummary

Modular Medical has finalized a $12 million public offering of common stock and warrants, securing critical funding at a premium to market price to address its immediate liquidity crisis and fund operations, despite causing significant dilution.

check_boxKey Events

• Public Offering Finalized

  Modular Medical, Inc. has finalized a public offering of 62,098,000 shares of common stock and 6,000,000 pre-funded warrants, along with accompanying common warrants to purchase up to 68,098,000 additional shares.

• Significant Capital Raise

  The offering is expected to generate approximately $10.9 million in net proceeds for the company, with a potential for an additional $12 million if all common warrants are exercised, providing a critical financial lifeline.

• Premium Pricing Achieved

  The shares and warrants were priced at $0.1762 per unit (common stock + common warrant) or $0.1752 per unit (pre-funded warrant + common warrant), which is at a premium to the last reported sale price of $0.1570 and today's stock price of $0.1711.

• Addresses Liquidity Crisis and Going Concern

  The proceeds will be used to repay the $250,000 drawn from the CEO's credit facility and fund general corporate purposes, including operations and commercialization of the Pivot product, directly addressing the company's immediate liquidity crisis and going concern warning.

auto_awesomeAnalysis

Modular Medical, Inc. has finalized the terms and pricing of its public offering, which was initiated with an S-1 registration on February 27, 2026, and previously announced in news on March 3, 2026. This 424B4 filing confirms the sale of 62,098,000 shares of common stock and 6,000,000 pre-funded warrants, along with accompanying common warrants to purchase an additional 68,098,000 shares. The offering is expected to generate approximately $10.9 million in net proceeds for the company, with a potential for an additional $12 million if all common warrants are exercised. This capital raise is critical for Modular Medical, which recently disclosed an immediate liquidity crisis and substantial doubt about its ability to continue as a going concern. The offering's pricing at $0.1762 per unit (common stock + common warrant) or $0.1752 per unit (pre-funded warrant + common warrant) is notable as it is at a premium to the last reported sale price of $0.1570 on March 2, 2026, and today's stock price of $0.1711, indicating investor confidence despite the company's financial distress. The proceeds will be used to repay the $250,000 drawn from the CEO's credit facility (secured on February 23, 2026) and fund operations, including the commercialization of its Pivot product, extending the company's runway. However, the offering will result in significant immediate dilution of approximately 87.6% for existing shareholders, with further substantial dilution possible upon the exercise of the accompanying common warrants.